The cannabidiol (CBD) hemp oil products produced by Medical Marijuana Inc. (OTC MJNA) have been changing lives of patients suffering from debilitating medical conditions such as epilepsy, Parkinson’s disease, chronic pain and cancer, and the trend shows no sign of stopping. It was announced on May 26 that the United States-based company received approval from the Mexican federal health agency COFEPRIS for over 20 additional import permits for its powerful cannabis oil.

“La Razon,” Mexico’s leading news journal, explained that medical marijuana is a $12-billion-dollar business in Mexico. Hemp CBD oil has been heralded for its significant potential in increasing the effectiveness of treatment for epilepsy and other chronic, debilitating conditions. Within the next 10 to 20 years, it is expected that one cannabis-based medical treatment could replace up to 40 percent of the drugs currently on the market for the treatment of neurodegenerative diseases.

Hemp Oil Effectiveness

Dr. Stuart Titus, CEO of Medical Marijuana, Inc., the company that produces Real Scientific Hemp Oil™ (RSHO™), says he is proud of the company’s THC-free formulation. Without THC, it is easier to get medical marijuana products approved for import into countries like Mexico, Brazil and Paraguay. THC is the component of marijuana that causes the feeling of euphoria and the other psychotropic effects associated with being high. Without THC, medical marijuana products can provide life-changing relief for sufferers of epilepsy, Parkinson’s disease and other chronic conditions without reducing cognitive function.

Recent Media Coverage for RSHO™ Products

With governments in Latin America and around the world realizing the benefits of RSHO’s™ revolutionary products, international media coverage has increased dramatically.

For instance, numerous Mexico national news outlets recently covered Medical Marijuana Inc.’s historic role in shaping the new cannabis market in Mexico, including a cover story in Mexico’s leading new journal La Razon. The more news spreads of RSHO™ and Medical Marijuana, Inc.’s other products, the more patients will be aware of an alternative to pharmaceutical drugs that are often nearly as debilitating as the conditions they treat.

Crisis” is a documentary that recently highlighted the historic legalization of cannabis products in Mexico. The documentary tells the story of a number of Mexican families and legalization advocates who fought for the right to treat affected children with cannabis oil products. The first family in Mexico to sue the federal government won in a landmark victory, gaining the right to import CBD hemp oil from Medical Marijuana, Inc.

International Markets

In the United States, where medical marijuana is selectively legal in multiple locations, legalization has been an uphill battle. Nonetheless, progress is being made with Ohio becoming the 25th U.S. state or district to legalize medical marijuana on June 9, 2016.  Including U.S. territories Puerto Rico and Guam, as well as the District of Columbia, more than 50% of the U.S. now has full-spectrum medical cannabis laws enacted. In addition, there are 16 U.S. states with limited medical cannabis laws enacted, which brings the total of all U.S. states, districts or territories with some form of cannabis law to 43.

In addition, Colorado and California have changed the medical marijuana market significantly. In California alone, the legal cannabis market is approximately $1.3 billion. Some changes are expected to occur in 2018, when official taxes will be established on the sale of recreational marijuana products. It is estimated that the market could grow to $10 to $12 billion each year in California over the course of the next 20 years.

On June 15, 2016, the Mexican senate unanimously approved legalization of medicinal marijuana in Mexico. What legalization in the U.S. and other countries means for patients and families is greater exposure and easier access to medicinal marijuana that can help with debilitating medical conditions.

Real Scientific Hemp Oil™ (RSHO™)

RSHO™ products are unlike any unregulated marijuana products because they are scientifically formulated in a controlled laboratory setting for maximum effectiveness. Each dose of THC-free RSHO™ oil is carefully calculated and formulated to provide effective treatment rather than a chemical high. For this reason, these products have become increasingly popular in treating adolescents. Children with epilepsy and chronic pain disorders can benefit significantly from the use of cannabis oil treatments without the harsh side effects common to other drugs.

One of the most notable benefits of RSHO™ oil is its reduction in the severity and frequency of seizures and other motor disturbances. Patients having dozens of seizures per day have seen dramatic reductions, some only experiencing seizures once every couple of months. These success stories demonstrate how important it is that RSHO™ products are made legal for the treatment of patients around the world.

About the Author

Stuart Smith is the CEO and Founder of is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and their services, please visit